Drug Profile
Research programme: ion channel blockers - Scion Pharmaceuticals
Alternative Names: S-XX5; S-XX6; SPI 860Latest Information Update: 29 Aug 2007
Price :
$50
*
At a glance
- Originator CeNeS Pharmaceuticals
- Class Small molecules
- Mechanism of Action Calcium channel antagonists; Ion channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atrial fibrillation; Neurological disorders; Neuropathic pain; Pain
Most Recent Events
- 29 Aug 2007 No development reported - Preclinical for Atrial fibrillation in USA (unspecified route)
- 29 Aug 2007 No development reported - Preclinical for Neurological disorders in USA (unspecified route)
- 29 Aug 2007 No development reported - Preclinical for Neuropathic pain in USA (unspecified route)